Valuation: Abbott Laboratories

Capitalization 175B 149B 138B 130B 242B 16,254B 247B 1,620B 632B 7,801B 656B 642B 27,818B P/E ratio 2026 *
24.6x
P/E ratio 2027 * 21.4x
Enterprise value 198B 169B 156B 147B 274B 18,447B 281B 1,839B 717B 8,854B 744B 728B 31,571B EV / Sales 2026 *
3.92x
EV / Sales 2027 * 3.52x
Free-Float
86.65%
Yield 2026 *
2.51%
Yield 2027 * 2.66%
1 day-2.36%
1 week-2.50%
Current month-2.31%
1 month-9.27%
3 months-20.35%
6 months-24.34%
Current year-19.95%
1 week 99.34
Extreme 99.34
103.84
1 month 99.34
Extreme 99.34
111.86
Current year 99.34
Extreme 99.34
129.46
1 year 99.34
Extreme 99.34
139.06
3 years 89.67
Extreme 89.674
141.23
5 years 89.67
Extreme 89.674
142.6
10 years 36.76
Extreme 36.76
142.6
Manager TitleAgeSince
Chief Executive Officer 52 30/03/2020
Director of Finance/CFO 53 31/08/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 75 09/10/2008
Director/Board Member 64 08/12/2011
Director/Board Member 67 08/12/2011
Change 5d. change 1-year change 3-years change Capi.($)
-2.36%-2.50%-19.44%-3.28% 175B
-0.80%+0.67%+5.66%+8.69% 112B
-0.51%-1.23%+14.93%+92.82% 62.41B
+1.74%+6.94%+89.04%+108.41% 62.17B
-0.80%-0.19%-22.55%-39.17% 43.91B
-0.20%+2.98% - - 37.01B
-2.53%+2.89%-4.87%-43.11% 24.64B
-0.52%+1.77%+2.51%+15.78% 21.83B
-1.47%-1.97%-25.20%+15.90% 19.83B
+0.83%+0.71%+8.51%-40.87% 19.45B
Average -0.66%+1.37%+5.40%+12.80% 57.79B
Weighted average by Cap. -0.96%+1.23%+4.28%+18.52%

Financials

2026 *2027 *
Net sales 50.61B 43.18B 39.9B 37.61B 70.04B 4,709B 71.69B 469B 183B 2,260B 190B 186B 8,060B 55.43B 47.29B 43.7B 41.19B 76.7B 5,157B 78.51B 514B 201B 2,475B 208B 204B 8,827B
Net income 7.09B 6.05B 5.59B 5.27B 9.81B 660B 10.04B 65.77B 25.66B 317B 26.61B 26.04B 1,129B 8.19B 6.99B 6.46B 6.08B 11.33B 762B 11.6B 75.95B 29.63B 366B 30.73B 30.07B 1,304B
Net Debt 23.56B 20.1B 18.58B 17.51B 32.61B 2,193B 33.38B 219B 85.28B 1,052B 88.43B 86.54B 3,753B 20.26B 17.28B 15.97B 15.05B 28.03B 1,885B 28.69B 188B 73.31B 905B 76.02B 74.4B 3,226B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
10/04/26 100.30 $ -2.36% 11,944,755
09/04/26 102.72 $ -0.81% 6,198,999
08/04/26 103.56 $ +1.70% 9,379,259
07/04/26 101.83 $ -0.46% 13,310,997
06/04/26 102.30 $ -0.55% 7,125,767
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
100.30USD
Average target price
131.44USD
Spread / Average Target
+31.05%

Quarterly revenue - Rate of surprise